- Home
- SGMO vs EPM Comparison
SGMO vs EPM Comparison
Compare SGMO & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMO | EPM |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | 11 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.1M | 124.2M |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SGMO | EPM |
|---|---|---|
| Price | $0.43 | $3.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $4.71 | ★ $4.93 |
| AVG Volume (30 Days) | ★ 5.5M | 465.5K |
| Earning Date | 11-06-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 13.41% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $32,875,000.00 | ★ $85,232,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $3.51 |
| 52 Week High | $2.73 | $5.70 |
Technical Indicators
Market Signals| Indicator | SGMO | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 32.76 |
| Support Level | $0.43 | $4.02 |
| Resistance Level | $0.49 | $3.62 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 3.99 | 10.10 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.